amobarbital has been researched along with Factitious Disorders in 3 studies
Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.
Factitious Disorders: Disorders characterized by physical or psychological symptoms that are not real, genuine, or natural.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McAllister, TW | 1 |
| Fisman, M | 1 |
| Marriage, K | 1 |
| Govorchin, M | 1 |
| George, P | 1 |
| Dilworth, C | 1 |
1 review available for amobarbital and Factitious Disorders
| Article | Year |
|---|---|
Overview: pseudodementia.
Topics: Adult; Age Factors; Aged; Amobarbital; Cognition Disorders; Depressive Disorder; Diagnosis, Differen | 1983 |
2 other studies available for amobarbital and Factitious Disorders
| Article | Year |
|---|---|
Pseudodementia and schizophrenia.
Topics: Aged; Alzheimer Disease; Amobarbital; Dementia; Factitious Disorders; Female; Humans; Schizophrenia | 1982 |
Use of an amytal interview in the management of factitious deaf mutism.
Topics: Adult; Amobarbital; Deafness; Factitious Disorders; Female; Humans; Munchausen Syndrome; Referral an | 1988 |